May 27, 2015 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - Amidst the health care industry’s seismic shift away from fee-for-service to value-based care, the pharmaceutical industry remains firmly at odds. Manufacturers need to recoup massive R&D costs for curative therapies and PBMs need to drive down costs for their plan sponsors. […]